Evidence map›Paper›PMID 34516566›Full record

ArticlePloS one2021

Defective expansion and function of memory like natural killer cells in HIV+ individuals with latent tuberculosis infection.

Kamakshi Prudhula Devalraju, Venkata Sanjeev Kumar Neela, Siva Sai Krovvidi, Ramakrishna Vankayalapati, Vijaya Lakshmi Valluri

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Tuberculosis in Pregnancy: Challenges of Immune Protection.The Journal of infectious diseases · 2026
    Review
  3. Article
  4. Review
  5. HLA-E/Frontiers in immunology · 2024
    Article
  6. Article
  7. Review
  8. Early innate cell interactions withFrontiers in immunology · 2023
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Kamakshi Prudhula DevalrajuImmunology and Molecular Biology Division, Blue Peter Public Health and Research Centre, LEPRA Society, Cherlapally, Hyderabad, Telangana, India.
Venkata Sanjeev Kumar NeelaImmunology and Molecular Biology Division, Blue Peter Public Health and Research Centre, LEPRA Society, Cherlapally, Hyderabad, Telangana, India.
Siva Sai KrovvidiDepartment of Biotechnology, Sreenidhi Institute of Science and Technology, Yamnampet, Ghatkesar, Hyderabad, Telangana, India.
Ramakrishna VankayalapatiDepartment of Pulmonary Immunology, Center for Biomedical Research, The University of Texas Health Center at Tyler, Texas, TX, United States of America.
Vijaya Lakshmi ValluriImmunology and Molecular Biology Division, Blue Peter Public Health and Research Centre, LEPRA Society, Cherlapally, Hyderabad, Telangana, India.ORCID 0000-0002-0462-4174
Lepra Society · INThe University of Texas Health Science Center at Tyler · US

Funding

IFN-γ independent inhibition of MTB growth in human macrophagesR01AI123310 · NIAID · UNIVERSITY OF TEXAS HLTH CTR AT TYLER · PI VANKAYALAPATI, RAMAKRISHNA · 2017 to 2020
$1.6M
Monocyte subpopulation in HIV+LTB+ individuals and development of active TBR21AI127178 · NIAID · UNIVERSITY OF TEXAS HLTH CTR AT TYLER · PI VANKAYALAPATI, RAMAKRISHNA · 2016 to 2017
$393k
T-regs mediated immune responses in LTBI HIV positive individualsR21AI120257 · NIAID · UNIVERSITY OF TEXAS HLTH CTR AT TYLER · PI VANKAYALAPATI, RAMAKRISHNA · 2015 to 2016
$386k
NIAID NIH HHS R01 AI123310NIAID NIH HHS R21 AI120257NIAID NIH HHS R21 AI127178
6 · The paper itself

Abstract

purposeTuberculosis (TB) is the leading cause of infectious disease related mortality, and only 10% of the infected individuals develop active disease. The likelihood of progression of latent tuberculosis infection (LTBI) to active TB disease is high in HIV infected individuals. Identification of HIV+ individuals at risk would allow treating targeted population, facilitating completion of therapy for LTBI and prevention of TB development. NK cells have an important role in T cell independent immunity against TB, but the exact role of NK cell subsets in LTBI and HIV is not well characterized.

methodsIn this study, we compared the expansion and function of memory like NK cells from HIV-LTBI+ individuals and treatment naïve HIV+LTBI+ patients in response to Mtb antigens ESAT-6 and CFP-10.

resultsIn freshly isolated PBMCs, percentages of CD3-CD56+ NK cells were similar in HIV+LTBI+ patients and healthy HIV-LTBI+ individuals. However, percentages of CD3-CD56+CD16+ NK cells were higher in healthy HIV-LTBI+ individuals compared to HIV+LTBI+ patients. HIV infection also inhibited the expansion of memory like NK cells, production of IL-32α, IL-15 and IFN-γ in response to Mtb antigens in LTBI+ individuals.

conclusionWe studied phenotypic, functional subsets and activation of memory like-NK cells during HIV infection and LTBI. We observed that HIV+LTBI+ patients demonstrated suboptimal NK cell and monocyte interactions in response to Mtb, leading to reduced IL-15, IFN-γ and granzyme B and increased CCL5 production. Our study highlights the effect of HIV and LTBI on modulation of NK cell activity to understand their role in development of interventions to prevent progression to TB in high risk individuals.

Indexed as

Immunologic MemoryAdultCell CommunicationCell ProliferationChemokinesGranzymesHIV InfectionsHumansInterferon-gammaInterleukin-15InterleukinsKiller Cells, NaturalLatent TuberculosisLymphocyte SubsetsMonocytesChemokinesGranzymesIL32 protein, humanInterferon-gammaInterleukin-15Interleukins

Identifiers

PMID34516566
PMCPMC8437280
OpenAlexW3199340483

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.